スタッフ紹介
中内 さくら
中内 さくら
氏名
中内 さくら
所属
東北大学加齢医学研究所 脳機能開発研究分野
学術論文
1) Jia Y, Yamazaki Y, Nakauchi S, Ito K, Sumikawa K. Nicotine facilitates LTP induction in oriens-lacunosum moleculare cells via Ca2+ entry through non-α7 nicotinic acetylcholine receptors. Eur J Neurosci. (in press)

2) Riera J, Ogawa T, Hatanaka R, Goto T, Sumiyoshi A, Enjieu Kadji H, Nakauchi S, Kawashima R. Concurrent observations of astrocytic Ca2+ activity and multisite extracellular potentials from an intact cerebral cortex. J. Biophoton. (2009) Oct, 15.

3) Jia Y, Yamazaki Y, Nakauchi S, Sumikawa K. Alpha2 nicotine receptors function as a molecular switch to continuously excite a subset of interneurons in rat hippocampal circuits.Eur J Neurosci. (2009) Apr, 29(8):1588-603.

4) Nakauchi S, Brennan RJ, Boulter J, Sumikawa K.Nicotine gates long-term potentiation in the hippocampal CA1 region via the activation of alpha2* nicotinic ACh receptors.Eur J Neurosci. (2007) May;25(9):2666-2681.

5) Nakauchi S, Yamazaki Y, Sumikawa K.Chronic nicotine exposure affects the normal operation of hippocampal circuits.Neuroreport. (2007) Jan 8;18(1):87-91. 

6) Guan X, Nakauchi S, Sumikawa K.Nicotine reverses consolidated long-term potentiation in the hippocampal CA1 region.Brain Res. (2006) Mar 17;1078(1):80-91. 

7) Kawada T, Nakazawa M, Nakauchi S, Yamazaki K, Shimamoto R, Urabe M, Nakata J, Hemmi C, Masui F, Nakajima T, Suzuki J, Monahan J, Sato H, Masaki T, Ozawa K, Toyo-Oka T.Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.Proc Natl Acad Sci U S A. (2002) Jan 22;99(2):901-906. 
学会発表
1) ALPHA2* NICOTINIC ACETHYLCHOLINE RECEPTORS AND LTP INDUCTION IN THE HIPPOCAMPAL CA1 REGION Sakura Nakauchi, Jorge Riera, Ryuta Kawashima, Katumi SumikawaIUPS 2009, Kyoto, Japan 2009. 7. 28-8.1

2) Pathway-specific effects of nicotine on excitatory synaptic activity in the hippocampal CA1 region.Sakura Nakauchi, Katumi Sumikawa Neuroscience, San Diego, California, 2007年11月3-7日

3) 遺伝子治療における目的外臓器の遺伝子発現 中内さくら,河田登美枝,中鶴陽子,仲澤幹雄,辺見智恵子,増井藤子,申偉秀,工藤佳久,豊岡照彦、第74回日本薬理学会年会,横浜,2001年3月21-23日

4) Fine structure and permeability of sarcolemma in cardiomyocytes that lacks dystrophin-associated glycoprotein (DAGC) at the end stage of heart failure and its amelioration by in vivo gene therapy.T. Toyo-oka, T. Kawada, M. Nakazawa, C. Hemmi, S. Fukuda, Y. Nakatsuru, M. Nakazawa, S. Nakauchi, W. S. Shin T and Toyo-okaAHA, Scientific Sessions 2001, Anaheim, November 11-14, 2001

5) Morphological, metabolic and physiological restorations and prognosis rescue of TO-2 hamsters with hereditary form of dilated cardiomyopathy (HDCM) by adeno-associated virus (AAV)-mediated gene therapy.T. Kawada, S. Nakauchi, M. Nakazawa, A. Sakamoto, M. Urabe, K, Yamazaki, R. Shimamoto, F. Masui, W. S. Shin, J. Suzuki, H. Sato and K. OzawaAHA, Scientific Sessions 2001, Anaheim, November 11-14, 2001, Inaugural Award

6) Long-term beneficial effects of hereditary dilated cardiomyopathy (HDCM) by somatic gene therapy.T. Kawada, M. Nakazawa, S. Nakauchi, A. Sakamoto, M. Urabe, W-S. Shin, K. Yamazaki, H. Satoh, K Ozawa and T. Toyo-oka第18回国際心臓研究学会日本部会,秋田,2001年 9月30-10月2日

7) Long-term rescue of hereditary form of dilated cardiomyopathy by rAAV mediated somatic gene therapy in TO-2 hamsters.T. Toyo-oka, T. Kawada, M. Nakazawa, H. Yoshida, S. Nakauschi, C. Hemmi, K. Yamazaki, M. Urabe, J. Monahan, R. Shimamoto, F. Masui, J. Suzuki, A. Sakamoto, H. Sato, S. Takeo, Y. Kudo and K. OzawaSatellite Meeting of the XXXIV Internatinal Union of Physiological Sciences and the Annual Scientific Meeting of the International Society for Heart Research, Brisbane, September 2-4, 2001
学会誌表紙
1) 中内さくら、リエラホルヘ、川島隆太、澄川勝美海馬CA1における2*二コチン性アセチルコリン受容体とLTP誘導“ALPHA2* NICOTINIC ACETHYLCHOLINE RECEPTORS AND LTP INDUCTION IN THE HIPPOCAMPAL CA1 REGION”日本生理学会雑誌 72巻3号 (in press)